Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece
Authors:
- 1 January 2020
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 26 (1) , 9-13
Abstract
The aim of this study was to study the molecular epidemiology of 16S rRNA-methylase (RMT)-producing clinical Acinetobacter baumannii isolates from hospitals in Athens, Greece. Single-patient A. baumannii clinical isolates, coresistant to amikacin and gentamicin ( n = 347), from five tertiary care hospitals, were submitted to minimum inhibitory concentration determination and molecular testing for carbapenemase and RMT genes. A. baumannii, resistant to amikacin and gentamicin, was isolated at participating institutions at a mean rate of 67.8%. Among them 93.7% harbored the armA . The vast majority (98.5%) of armA positive isolates were OXA-23 producers, assigned mainly (99.4%) to sequence group G1, corresponding to international clone (IC) II. Four isolates (all from the same hospital) were OXA-24 producers (1.2%), assigned to G6 corresponding to CC78 and only one isolate was OXA-58-producer, assigned to G2 (IC I). Apramycin was the most active agent inhibiting 99.7% of the isolates at ≤64 mg/L, whereas colistin, trimethoprim/sulfamethoxazole, minocycline, and tigecycline exhibited only sparse activity (S, armA was observed among A. baumannii strains isolated in participating hospitals in Athens, which were mainly OXA-23 producers and belonged to IC II. Apramycin is a structurally unique aminoglycoside, currently used as a veterinary agent. Although it has not been evaluated for clinical use, apramycin appears worthy of further investigation for repurposing as a human therapeutic against difficult-to-treat pathogens.Keywords
This publication has 25 references indexed in Scilit:
- Novel Variants of AbaR Resistance Islands with a Common Backbone in Acinetobacter baumannii Isolates of European Clone IIAntimicrobial Agents and Chemotherapy, 2012
- Prevalence of 16S rRNA methylase genes in Enterobacteriaceae isolates from a Greek University HospitalClinical Microbiology and Infection, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Acinetobacter infection – an emerging threat to human healthIUBMB Life, 2011
- Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)Journal of Antimicrobial Chemotherapy, 2011
- Aminoglycoside modifying enzymesDrug Resistance Updates, 2010
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolatesJournal of Antimicrobial Chemotherapy, 2010
- Synthesis and Spectrum of the Neoglycoside ACHN-490Antimicrobial Agents and Chemotherapy, 2010
- Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic CloneJournal of Clinical Microbiology, 2010
- Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in KoreaDiagnostic Microbiology and Infectious Disease, 2006